![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Han, Se Young; Mrozek, Krzysztof; Voutsinas, Jenna; Wu, Qian; Morgan, Elizabeth A.; Vestergaard, Hanne; Ohgami, Robert; Kluin, Philip M.; Kristensen, Thomas Kielsgaard; Pullarkat, Sheeja; Moller, Michael Boe; Schiefer, Ana-Iris; Baughn, Linda B.; Kim, Young; Czuchlewski, David; Hilberink, Jacobien R.; Horny, Hans-Peter; George, Tracy I.; Dolan, Michelle; Ku, Nam K.; Yi, Cecilia Arana; Pullarkat, Vinod; Kohlschmidt, Jessica; Salhotra, Amandeep; Soma, Lori; Bloomfield, Clara D.; Chen, Dong; Sperr, Wolfgang R.; Marcucci, Guido; Cho, Christina; Akin, Cem; Gotlib, Jason; Broesby-Olsen, Sigurd; Larson, Melissa; Linden, Michael A.; Deeg, H. Joachim; Hoermann, Gregor; Perales, Miguel-Angel; Hornick, Jason L.; Litzow, Mark R.; Nakamura, Ryotaro; Weisdorf, Daniel; Borthakur, Gautam; Huls, Gerwin; Valent, Peter; Ustun, Celalettin und Yeung, Cecilia C. S.
(2021):
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).
In: Blood Advances, Bd. 5, Nr. 10: S. 2481-2489
2018
Ustun, Celalettin; Morgan, Elizabeth; Moodie, Erica E. M.; Pullarkat, Sheeja; Yeung, Cecilia; Broesby-Olsen, Sigurd; Ohgami, Robert; Kim, Young; Sperr, Wolfgang; Vestergaard, Hanne; Chen, Dong; Kluin, Philip M.; Dolan, Michelle; Mrozek, Krzysztof; Czuchlewski, David; Horny, Hans-Peter; George, Tracy I.; Kristensen, Thomas Kielsgaard; Ku, Nam K.; Yi, Cecilia Arana; Moller, Michael Boe; Marcucci, Guido; Baughn, Linda; Schiefer, Ana-Iris; Hilberink, J. R.; Pullarkat, Vinod; Shanley, Ryan; Kohlschmidt, Jessica; Coulombe, Janie; Salhotra, Amandeep; Soma, Lori; Cho, Christina; Linden, Michael A.; Akin, Cem; Gotlib, Jason; Hoermann, Gregor; Hornick, Jason; Nakamura, Ryo; Deeg, Joachim; Bloomfield, Clara D.; Weisdorf, Daniel; Litzow, Mark R.; Valent, Peter; Huls, Gerwin; Perales, Miguel-Angel und Borthakur, Gautam
(2018):
Core-binding factor acute myeloid leukemia with t(8;21) Risk factors and a novel scoring system (I-CBFit).
In: Cancer Medicine, Bd. 7, Nr. 9: S. 4447-4455